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Abstract
Background: Potassium voltage-gated channel, KQT-like subfamily, member 1 (KCNQ1) is thought to be an important
candidate gene of diabetes. Several single nucleotide polymorphisms (SNPs) in a 40-kb linkage disequilibrium (LD) block in
its intron 15 have been identified to be associated with diabetes in East Asian populations in recent genome-wide
association studies. The aim of this study was to investigate whether KCNQ1 polymorphisms influence the levels of the
metabolic phenotypes in general Chinese populations.
Methodology/Principal Findings: We investigated the associations of two SNPs (rs2237892 and rs2237895) in the
aforementioned 40-kb LD block, a missense variant rs12720449 (P448R) in exon 10, and a synonymous variant rs1057128
(S546S) in exon 13 with metabolic phenotypes in a Uyghur population (n=478) and replicated these associations in a Han
population (n=2,485). We found that rs2237892-T allele was significantly associated with decreased triglyceride levels
(pcombined=0.001). The minor G allele of the rs12720449, with sharp difference of the allelic frequency between European
and East Asian populations (0.2% versus 14%, respectively), was associated with a lower triglyceride levels than G allele in
Uyghur subjects (p=0.004), in Han subjects (p=0.052), and in subjects of meta-analysis (pcombined=0.001). Moreover, the
minor A allele of the rs1057128 was also associated with decreased triglyceride levels in meta-analysis (pcombined=0.010).
Conclusions: To the best of our knowledge, this is the first report associating a missense mutation of KCNQ1, rs12720449,
with triglyceride levels. Rs2237892, representing the 40-kb LD block, is also associated with triglyceride levels in Han
population. Further studies are required to replicate these findings in other East Asian populations.
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Introduction
The potassium voltage-gated channel, KQT-like subfamily,
member 1 (KCNQ1), which encodes the pore-forming voltage-
gated K
+ channel subunit KvLQT1 and is widely expressed in
myocardial tissue, plays a key role in the repolarization of the
cardiac action potential and in the transport of water and salt in
epithelial tissues [1–3]. Loss-of-function and gain-of-function
mutations in this gene have been associated with cardiac long
QT syndrome, Lange-Nielsen cardioauditory syndrome, atrial
fibrillation, and congenital deafness [2–6].
KCNQ1 is expressed in the inner ear, stomach, intestine, liver,
kidney, and pancreatic islets [5]. In the pancreas, KCNQ1
contributes to the regulation of insulin secretion, and a blockade
of the KvLQT1 channel may lead to increased insulin secretion
[7,8]. Recently, two independent genome-wide association studies
(GWAS) revealed that several SNPs (including rs2237892,
rs2237895, rs2283228, and rs2237897) within a 40-kb linkage
disequilibrium (LD) block in intron 15 of KCNQ1 were consistently
associated with type 2 diabetes and the impairment of insulin
secretion in East Asian populations [9,10]. For these SNPs, the
associations with type 2 diabetes have been replicated, predom-
inantly not only in East Asian ethnic groups, including Chinese
[11,12] and Singaporean populations [13], but also in Euro-
Caucasian populations from Denmark [10,14] and Sweden [15].
Moreover, rs2237892 and rs2237895 have also been associated
with metabolic phenotypes, such as glucose and body mass index
(BMI) levels, in East Asian populations [13,16].
Because KCNQ1 is critical for the regulation of insulin secretion
[5] and insulin is important for the regulation of metabolic
phenotypes, we hypothesized that genetic polymorphisms in the
KCNQ1 gene may underlie differences in metabolic phenotypes,
such as triglyceride (TG) and total cholesterol (TC). In addition to
SNPs located in the 40-kb LD region, the pathogenesis effects of
another two important SNPs in the exon regions of the KCNQ1
gene, rs1057128 and rs12720449, need to be explored. Synony-
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gene, has been found to be associated with various cardiac
arrhythmias, such as Long-QT syndrome, atrial flutter, and atrial
fibrillation, in European and Chinese individuals [17,18]. Non-
synonymous variant rs12720449 (P448R), located in exon 10 of
KCNQ1, was also found to be associated with Long-QT syndrome
[19,20]. The minor allele frequency (MAF) of this SNP is distinct
between Europeans and East Asians (0.2% and 5.8%, respective-
ly), according to the NCBI SNP databank (http://www.ncbi.nlm.
nih.gov/projects/SNP/snp_ref.cgi?rs=12720449). No prior stud-
ies have investigated the association between these two SNPs
(rs1057128, rs12720449) and metabolic phenotypes.
The aim of the present study was to investigate the effects of
rs1057128, rs12720449, and two SNPs (rs2237892 and rs2237895)
within the aforementioned 40-kb LD block on several metabolic
phenotypes. We first observed the associations of these four SNPs
with BMI, waist-to-hip ratio (WHR), systolic blood pressure (SBP),
diastolic blood pressure (DBP), glucose (Glu), triglyceride (TG),
and total cholesterol (TC) in a Uyghur population, an ethnic group
with European and East Asian ancestry. Then we observed the
associations in a Han population, the ethnic group that accounts
for 94% of the Chinese populations, with a larger sample size.
Results
The genotypic and allelic frequencies of the studied SNPs
The genomic characteristics of rs1057128, rs2237892,
rs2237895, and rs12720449 were summarized in Table 1. All
SNPs were consistent with Hardy–Weinberg expectations in both
populations (p.0.01). The MAFs of rs12720449 were different for
the Han and Uyghur populations in the present study (0.14 and
0.05, respectively). Pair-wise linkage analysis with the four SNPs
showed weak LDs (data not shown). To the best of our knowledge,
this is the first study investigating SNPs in KCNQ1 in a Uyghur
population. Because the sample size for the Uyghur population
was relatively small, we compared the metabolic phenotypes of
rare allele carriers (CG/GG for rs12720449) with those of non-
carriers in the subsequent analysis. The analysis was performed as
previously described in the original GWAS [21].
The association between the four SNPs in KCNQ1 and
plasma TG levels
We presented the association results between the four SNPs in
KCNQ1 and plasma TG levels in Table 2. For SNP rs12720449,
significantly lower TG levels were observed in CG/GG carriers
(0.9460.35) than in CC carriers (1.0860.35) (p=0.004) in the
Uyghur population. A preliminary significant association was also
observed in the Han population, and the mean TG levels of GG,
CG, and CC carriers were 0.8760.30, 1.0360.92, and
1.0860.96, respectively (p=0.052). The minor alleles of
rs1057128 (A) and rs2237892 (T) were significantly associated
with decreased TG levels in Han subjects (p=0.011 for both
alleles).
To investigate allelic associations with TG levels, we performed
a meta-analysis across Uyghur and Han datasets (Table 2). We
found that the minor alleles of rs12720449 (G), rs1057128 (A), and
rs2237892 (T) decreased TG levels at a multiple correction
threshold level of p,0.0125 (p=0.001, 0.010 and 0.001,
respectively). We also evaluated these associations by including
all four SNPs in one model, and the associations between
Table 1. Genomic characteristics of the four SNPs in studied subjects.
SNPs Gene region Major/Minor Allele Population Genotyped frequence MAF p value*
rs1057128 Exon 13 G/A Han 1207/1053/211 0.30 0.381
Uyghur 252/181/34 0.27 0.848
rs2237892 Intron 15 C/T Han 1161/1048/254 0.32 0.967
Uyghur 310/130/16 0.18 0.605
rs12720449 Exon 10 C/G Han 1857/559/60 0.14 0.022
Uyghur 425/46/2 0.05 0.533
rs2237895 Intron 15 A/C Han 1186/1048/238 0.31 0.769
Uyghur 173/222/77 0.40 0.684
*Deviation from Hardy–Weinberg expectation for the variants was tested using the chi-square statistic.
doi:10.1371/journal.pone.0034229.t001
Table 2. Association between studied SNPs in KCNQ1 and
plasma TG levels.





















CC 1.0560.34 1.1361.03 0.851 0.095 0.040
p values were inferred from GLM adjusted for age gender smoking and alcohol
drinking.
Bold fonts represent significant difference (p,0.0125).
doi:10.1371/journal.pone.0034229.t002
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significant (p=0.007, 0.001, and 0.001, respectively).
The association between the four SNPs and the principal
components of the metabolic phenotypes
To further validate our results, we conducted a principal
component analysis in the Han population using nine metabolic-
related traits: BMI, WHR, SBP, DBP, Glu, HDL, LDL, TG, and
TC. First, we identified two principal components (PC) of these
traits to generate canonical variables (PC1 and PC2) (Table 3).
Next, we performed a classic single-trait approach to test the
associations between SNPs and the canonical variables. As shown
in Table 3, PC2 is strongly correlated with TG (with an eigenvalue
of 0.98). All four SNPs were significantly associated with PC2 at a
threshold level of p,0.05 (p=0.017, 0.020, 0.043, and 0.050), but
these association did not reach the multiple correction threshold
level of p,0.0125.
The association between SNPs in KCNQ1 and other
metabolic phenotypes excluding TG
We investigated the relationships of the four SNPs in KCNQ1
with other metabolic-related parameters, including BMI, WHR,
SBP, DBP, Glu, HDL, LDL, and TC. We found a significant
association between rs1057128 and SBP in the Han population at
the significant level of 0.0125. In the Uyghur population, we found
a significant association between rs2237892 and WHR at the
significant level of 0.05 (Table 4). We also performed a meta-
analysis across the two datasets for the Uyghur and Han
populations, but we found that none of associations reached the
multiple correction threshold level of p,0.0125.
Discussion
In this population-based association study, we replicated the
association between rs2237892, a SNP in intron 15 of KCNQ1
gene, and TG levels. We also identified a novel association
between rs1057128 (S546S), which is located in exon 13 of the
KCNQ1 gene, and TG levels. Most importantly, we identified a
missense mutation, rs12720449 (P448R), located in exon 10 of
KCNQ1, associated with TG levels.
Intron 15 of the KCNQ1 gene spans approximately 70 kb on
chromosome 11p15.5. An extremely long LD block, covering
approximately 40 kb, was observed in a Japanese population, and
several SNPs (including rs2237892, rs2237895, rs2283228, and
rs2237897) located in this LD block were found to be associated
with diabetes in Japanese individuals [9,10]. However, the LD
block in this 40-kb region was weak in other ethnically distinct East
Asian groups, such as Singaporean and Han Chinese populations
[13], and the associations of these SNPs with diabetes were not
consistently replicated in these East Asian populations
[11,13,16,22]. Moreover, the associations of the SNPs in this
region with other metabolic phenotypes, such as lipid levels,
assessed in East Asian populations were inconsistent [23]. In the
present study, we did not observe an association between glucose
levels and the two SNPs, rs2237892 and rs2237895, within this
region. However, we detected associations between rs2237892 and
TG levels, rs2237895 and LDL levels, and rs2237895 and TC
levels. In the Japanese population, the diabetes causal variant may
be in LD with this 40-kb region. In other East Asian ethnic groups,
such as Han Chinese or Singaporean populations, different
variants affecting lipid metabolic regulation may be in LD with
rs2237892 or rs2237895 [13]. Further studies will need to be
performed to identify these functional variants.
In the present study, rs1057128 was associated with TG levels in
the Han population. This SNP was originally identified in
association with various cardiac arrhythmias [17,18]. Although
rs1057128 (S546S) is a synonymous variant, there is evidence
indicating that synonymous mutations can affect the thermody-
namic stability of mRNA secondary structures or affect splicing
through phenomena such as exon skipping; therefore, synonymous
mutations may not be neutral in evolution [24]. Additionally, a
small domain between residues 589 and 620 in the KCNQ1 C
terminus may function as an assembly domain for KCNQ1 subunits


















The PCA results were gained from Uncorrected Correlation Matrix.
doi:10.1371/journal.pone.0034229.t003








WHR 0.8860.09 0.8860.07 0.9360.20 0.020
Chinese Han
rs1057128
SBP 126.29618.24 127.88619.13 124.97618.71 0.011
rs12720449
LDL 1.7461.04 1.9261.02 2.2660.93 0.015
rs2237895
LDL 1.9061.04 1.7361.03 1.6461.01 0.013
TC 4.2861.60 4.4061.75 4.5862.23 0.020
Meta-analysis
rs1057128
SBP 127.90620.52 128.66620.41 125.36618.84 0.018
p values were inferred from GLM adjusted for age, gender, smoking, and
alcohol drinking.
doi:10.1371/journal.pone.0034229.t004
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functional potassium channels are not produced. Rs1057128 is
located in the KCNQ1 C terminus close to this domain and may
therefore affect the functional protein through this mechanism.
The most important finding of the present study was the
association between rs12720449 in KCNQ1 and TG levels.
rs12720449 (P448R), a missense mutation located in exon 10, is
a functional variant, and the G allele of rs12720449 can increase
channel current by two-fold [19]. The MAFs of this variant are
noticeably distinct among different ethnic groups, with <15% in
East Asians [20,26,27], <0.2% in Europeans, and <6% in
Uyghurs, an ethnic group with European and East Asian ancestry.
rs12720449 was originally identified as a polymorphism associated
with cardiac arrhythmia in people of European descent and was
not generally considered to be associated with polygenic diseases,
such as dyslipidemia, possibly as a result of its low frequency
(0.2%) in European populations [28,29]. In the present study, this
variant was found to be associated with TG levels in both an East
Asian population (Han) and an admixed population (Uyghur).
However, the underlying mechanism remains unclear, and further
studies are needed to elucidate the roles of rs12720449 in
evolutionary biology and complex phenotypes.
We also identified several associations between KCNQ1
polymorphisms and other metabolic phenotypes at a threshold
of p,0.05 (e.g., rs12720449 and LDL, rs2237892 and WHR,
rs2237895 and LDL, and rs2237895 and TC), but we did not
detect any association with glucose levels in either Uyghur or Han
populations. These variants may result in an increased expression
of KCNQ1 and a subsequent increase in insulin secretion in the
pancreatic b cells [8]. Increased insulin inhibits glucose production
and stimulates lipid synthesis, which may selectively increase
circulating lipid levels without increasing blood glucose levels [30].
In light of the present findings, KCNQ1 may have different effects
on the complex lipid and glucose phenotypes.
There are some advantages and disadvantages in our study. The
major advantage of the present study is the population-based
approach, which overcomes the potential selection bias associated
with hospital-based designs. However, this study also has some
limitations: first, only four important SNPs in the KCNQ1 gene
were examined for possible association with metabolic-related
parameters, although other associated variants may exist; second,
no functional experiments were performed to validate our results;
third, the sample size of the present study (N=2963) was relatively
small, which limited the statistic power for identifying associations
between genetic variants and phenotypes with low prevalence rate
(i.e., the fact that only 20 subjects had type 2 diabetes prohibited us
to measure the relationship of these variants with diabetes risk).
In summary, we found that several polymorphisms in the
KCNQ1 gene were associated with metabolic phenotypes, espe-
cially TG levels, in Han Chinese and/or in Uyghur populations.




The Uyghur subjects in this study included 478 individuals (273
men and 205 women with a mean age of 52.95611.28 years)
randomly recruited from March to May 2005 and April 2006 from
four villages in Tulupan District, Xinjiang Uyghur Autonomous
Region, China. The 2,485 Han subjects in this study were
randomly selected from the baseline samples of the Taizhou
Longitudinal Study (TZL). TZL, which was initiated in July 2007,
was an open-ended prospective study with very broad research
aims. The design and baseline characteristics of this study have
been previously described [31].
Subjects who reported receiving medications for the treatment
of metabolic-related diseases were excluded. Subjects who
reported having tumors, autoimmune diseases, or hematological
diseases were also excluded. Written informed consent was
obtained from each participant, and all protocols were approved
by the Human Ethics Committee of Fudan University.
Data collection
A standardized interview was conducted by trained personnel,
and detailed information was collected concerning medical history
and lifestyle characteristics, such as smoking and alcohol
consumption. All participants received a physical examination
and blood tests at a local hospital after overnight fasting. A
standardized mercury sphygmomanometer was used to measure
SBP and DBP, and these measurements were performed by two
cardiologists. Body weight and height were measured with subjects
wearing only light indoor clothing and without shoes. BMI was
calculated by dividing weight (kg) by height squared (m
2). The
waist circumference was measured midway between the caudal
point of the costal arch, as palpated laterally, and the iliac crest.
The hip circumference was measured at the symphysis-trochanter
femoris level. WHR was calculated by dividing the waist
circumference by the hip circumference. The blood specimens
were drawn after overnight fasting, immediately subjected to
centrifugation, and analyzed within 8 h for Glu, TG, and TC. The
distribution of the clinical parameters is listed in Table 5.
Genotyping
Blood samples were collected into EDTA-containing recepta-
cles, and genomic DNA was extracted using a standard method.
Sample DNA (10 ng) was amplified by PCR according to the
manufacturer’s instructions. Genotyping of the four SNPs in
KCNQ1, rs1057128(G.A), rs2237892(C.T), rs2237895(A.C),
and rs12720449(C.G) was performed using the TaqMan SNP
genotyping assay (Applied Biosystems, Foster City, CA, USA). The
Table 5. Clinical characteristics of studied subjects.
Uyghur Han
Number of subjects 478 2,485
Male/Female 273/205 1253/1232
Smoking(yes/no) 104/372 104/856/1525
Alcohol drinking(yes/no) 30/439 765/1720
Tea drinking(yes/no) N.M 647/1835
Age(year, mean 6 SD) 52.95611.28 57.12 612.16
BMI(kg/m
2, mean 6 SD) 25.5764.21 23.9163.53
WHR(mean 6 SD) 0.8860.09 0.8960.06
SBP(mm Hg, mean 6 SD) 134.25626.70 126.89618.67
DBP(mm Hg, mean 6 SD) 81.61614.62 83.59610.58
LDL(mmol/L, mean 6 SD) N.M 1.8061.03
HDL(mmol/L, mean 6 SD) N.M 1.3760.19
Glu(mmol/L, mean 6 SD) 5.5761.49 5.8861.71
TG(mmol/L, mean 6 SD) 1.0660.35 1.0660.94
TC(mmol/L, mean 6 SD) 4.2461.02 4.3661.75
Smoking status in Han indicated never/former/current.
N.M=no measurement.
doi:10.1371/journal.pone.0034229.t005
KCNQ1 Polymorphisms and Lipid Levels
PLoS ONE | www.plosone.org 4 March 2012 | Volume 7 | Issue 3 | e34229genotyping success rates and concordance rates at all four loci
were .99% based on 12% duplicate samples (n=380).
Statistical analysis
Deviation from Hardy–Weinberg expectation for the variants
was tested using the chi-square statistic. Haplotype inference was
conducted using Haploview software [32]. We treated the
metabolic phenotypes (BMI, WHR, SBP, DBP, FBG, LDL,
HDL, TG, and TC) as quantitative traits. Because these traits
exhibited a skewed distribution, we normalized these traits using
the Box-Cox method, which can be used to automatically identify
a suitable power transformation for the data. To estimate the
association of the variants with the metabolic parameters, we
applied a general linear regression model under an additive model,
adjusting for sex, age, smoking, and drinking, with the normalized
BMI, WHR, SBP, DBP, FBG, LDL, HDL, TG, and TC. Each
SNP was separately entered into the model as the explanatory
variable. A pre-specified threshold of p,0.0125 was used for
multiple correction significance (corresponding to p,0.05 after
adjusting for four loci). We also performed a principal component
analysis on the nine variables representing metabolic phenotypes
in the Han population. The association of the variants in KCNQ1
with changes in the extracted principal components was estimated
using a general linear regression model. All analyses were
performed using SAS statistical software (release 8.2, SAS Institute
Inc, Cary, NC, USA).
Acknowledgments
We thank the members of the survey teams and the participants for their
contributions to this study.
Author Contributions
Conceived and designed the experiments: XfW LJ YjY. Performed the
experiments: XdC SyL LjZ. Analyzed the data: XdC QqP XfW.
Contributed reagents/materials/analysis tools: YjY XfW LJ. Wrote the
paper: XdC XfW.
References
1. Barhanin J, Lesage F, Guillemare E, Fink M, Lazdunski M, et al. (1996)
KvLQT1 and IsK (minK) proteins associate to form the IKs cardiac potassium
current. Nature 384: 78.
2. Wang Q, Curran ME, Splawski I, Burn TC, Millholland JM, et al. (1996)
Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause
cardiac arrhythmias. Nature Genetics 12: 17–23.
3. Neyroud N, Tesson F, Denjoy I, Leibovici M, Donger C, et al. (1997) A novel
mutation in the potassium channel gene KVLQT1 causes the Jervell and Lange-
Nielsen cardioauditory syndrome. Nature Genetics 15: 186–189.
4. Chen YH, Xu SJ, Bendahhou S, Wang XL, Wang Y, et al. (2003) KCNQ1
gain-of-function mutation in familial atrial fibrillation. Science 299: 251.
5. Lee MP, Ravenel JD, Hu RJ, Lustig LR, Tomaselli G, et al. (2000) Targeted
disruption of the Kvlqt1 gene causes deafness and gastric hyperplasia in mice.
Journal of Clinical Investigation 106: 1447–1455.
6. Casimiro MC, Knollmann BC, Ebert SN, Vary JC, Greene AE, et al. (2001)
Targeted disruption of the KCNQ1 gene produces a mouse model of Jervell and
Lange–Nielsen Syndrome. Proceedings of the National Academy of Sciences 98:
2526.
7. Demolombe S, Franco D, de Boer P, Kuperschmidt S, Roden D, et al. (2001)
Differential expression of KvLQT1 and its regulator IsK in mouse epithelia.
American Journal of Physiology-Cell Physiology 280: C359.
8. Ullrich S, Su J, Ranta F, Wittekindt OH, Ris F, et al. (2005) Effects of I Ks
channel inhibitors in insulin-secreting INS-1 cells. Pflu ¨gers Archiv European
Journal of Physiology 451: 428–436.
9. Yasuda K, Miyake K, Horikawa Y, Hara K, Osawa H, et al. (2008) Variants in
KCNQ1 are associated with susceptibility to type 2 diabetes mellitus. Nature
genetics 40: 1092–1097.
10. Unoki H, Takahashi A, Kawaguchi T, Hara K, Horikoshi M, et al. (2008) SNPs
in KCNQ1 are associated with susceptibility to type 2 diabetes in East Asian and
European populations. Nature genetics 40: 1098–1102.
11. Liu Y, Zhou DZ, Zhang D, Chen Z, Zhao T, et al. (2009) Variants in KCNQ1
are associated with susceptibility to type 2 diabetes in the population of mainland
China. Diabetologia 52: 1315–1321.
12. Hu C, Wang C, Zhang R, Ma X, Wang J, et al. (2009) Variations in KCNQ1
are associated with type 2 diabetes and beta cell function in a Chinese
population. Diabetologia 52: 1322–1325.
13. Tan JT, Nurbaya S, Gardner D, Ye S, Tai ES, et al. (2009) Genetic Variation in
KCNQ1 Associates With Fasting Glucose and b-Cell Function. Diabetes 58:
1445.
14. Holmkvist J, Banasik K, Andersen G, Unoki H, Jensen TS, et al. (2009) The type
2 diabetes associated minor allele of rs2237895 KCNQ1 associates with reduced
insulin release following an oral glucose load. PLoS One 4: e5872.
15. Jonsson A, Isomaa B, Tuomi T, Taneera J, Salehi A, et al. (2009) A variant in
the KCNQ1 gene predicts future type 2 diabetes and mediates impaired insulin
secretion. Diabetes 58: 2409.
16. Qi Q, Li H, Loos RJF, Liu C, Wu Y, et al. (2009) Common variants in KCNQ1
are associated with type 2 diabetes and impaired fasting glucose in a Chinese
Han population. Human molecular genetics 18: 3508.
17. Aydin A, B Hring S, Dahm S, Guenther UP, Uhlmann R, et al. (2005) Single
nucleotide polymorphism map of five long-QT genes. Journal of molecular
medicine 83: 159–165.
18. Zhang Y, Chang B, Hu S, Wang D, Fang Q, et al. (2008) Single Nucleotide
Polymorphisms and Haplotype of Four Genes Encoding Cardiac Ion Channels
in Chinese and their Association with Arrhythmia. Annals of Noninvasive
Electrocardiology 13: 180–190.
19. Westenskow P, Splawski I, Timothy KW, Keating MT, Sanguinetti MC (2004)
Compound mutations: a common cause of severe long-QT syndrome.
Circulation 109: 1834.
20. Yang P, Kanki H, Drolet B, Yang T, Wei J, et al. (2002) Allelic variants in long-
QT disease genes in patients with drug-associated torsades de pointes.
Circulation 105: 1943–1948.
21. Richards JB, Rivadeneira F, Inouye M, Pastinen TM, Soranzo N, et al. (2008)
Bone mineral density, osteoporosis, and osteoporotic fractures: a genome-wide
association study. The Lancet 371: 1505–1512.
22. Chen Z, Zhang X, Ma G, Qian Q, Yao Y (2010) Association study of four
variants in KCNQ1 with type 2 diabetes mellitus and premature coronary artery
disease in a Chinese population. Molecular biology reports 37: 207–212.
23. Chen Z, Yin Q, Ma G, Qian Q (2010) KCNQ1 gene polymorphisms are
associated with lipid parameters in a Chinese Han population. Cardiovascular
Diabetology 9: 35.
24. Carlini DB, Chen Y, Stephan W (2001) The relationship between third-codon
position nucleotide content, codon bias, mRNA secondary structure and gene
expression in the drosophilid alcohol dehydrogenase genes Adh and Adhr.
Genetics 159: 623.
25. Schmitt N, Schwarz M, Peretz A, Abitbol I, Attali B, et al. (2000) A recessive C-
terminal Jervell and Lange-Nielsen mutation of the KCNQ1 channel impairs
subunit assembly. The EMBO journal 19: 332–340.
26. Liang L, Du ZD, Cai LL, Wu JX, Zheng T, et al. (2003) A novel KCNQ1
mutation in Chinese with congenital long QT syndrome]. Zhonghua er ke za
zhi. Chinese journal of pediatrics 41: 724.
27. Sharma D, Glatter KA, Timofeyev V, Tuteja D, Zhang Z, et al. (2004)
Characterization of a KCNQ1/KVLQT1 polymorphism in Asian families with
LQT2: implications for genetic testing. Journal of molecular and cellular
cardiology 37: 79–89.
28. Kathiresan S, Willer CJ, Peloso GM, Demissie S, Musunuru K, et al. (2008)
Common variants at 30 loci contribute to polygenic dyslipidemia. Nature
genetics 41: 56–65.
29. Teslovich TM, Musunuru K, Smith AV, Edmondson AC, Stylianou IM, et al.
(2010) Biological, clinical and population relevance of 95 loci for blood lipids.
Nature 466: 707–713.
30. Chavez JA, Summers SA (2010) Lipid oversupply, selective insulin resistance,
and lipotoxicity: molecular mechanisms. Biochimica et Biophysica Acta (BBA)-
Molecular and Cell Biology of Lipids 1801: 252–265.
31. Wang X, Lu M, Qian J, Yang Y, Li S, et al. (2009) Rationales, design and
recruitment of the Taizhou Longitudinal Study. BMC Public Health 9: 223.
32. Johnson GCL, Esposito L, Barratt BJ, Smith AN, Heward J, et al. (2001)
Haplotype tagging for the identification of common disease genes. Nature
genetics 29: 233–237.
KCNQ1 Polymorphisms and Lipid Levels
PLoS ONE | www.plosone.org 5 March 2012 | Volume 7 | Issue 3 | e34229